期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 24, 期 21, 页码 -出版社
MDPI
DOI: 10.3390/ijms242116010
关键词
breast cancer stem cells; miRNAs; diagnostic; prognostic; signature
Breast cancer is the most diagnosed cancer in women and the second most common cancer globally. Recent research has shown that breast cancer stem cells have unique characteristics and functions, playing a crucial role in treatment resistance, recurrence, and metastasis. miRNAs have emerged as potential regulators of breast cancer stem cells, modulating gene expression and influencing the self-renewal, differentiation, and tumor-promoting pathways of these cells. Understanding the role of miRNAs in breast cancer stem cells holds great promise for improving diagnosis and prognosis.
Breast cancer (BC) is the most diagnosed cancer in women and the second most common cancer globally. Significant advances in BC research have led to improved early detection and effective therapies. One of the key challenges in BC is the presence of BC stem cells (BCSCs). This small subpopulation within the tumor possesses unique characteristics, including tumor-initiating capabilities, contributes to treatment resistance, and plays a role in cancer recurrence and metastasis. In recent years, microRNAs (miRNAs) have emerged as potential regulators of BCSCs, which can modulate gene expression and influence cellular processes like BCSCs' self-renewal, differentiation, and tumor-promoting pathways. Understanding the miRNA signatures of BCSCs holds great promise for improving BC diagnosis and prognosis. By targeting BCSCs and their associated miRNAs, researchers aim to develop more effective and personalized treatment strategies that may offer better outcomes for BC patients, minimizing tumor recurrence and metastasis. In conclusion, the investigation of miRNAs as regulators of BCSCs opens new directions for advancing BC research through the use of bioinformatics and the development of innovative therapeutic approaches. This review summarizes the most recent and innovative studies and clinical trials on the role of BCSCs miRNAs as potential tools for early diagnosis, prognosis, and resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据